P-055: TRIAL IN PROGRESS: A PHASE 2, OPEN-LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF THE ERYTHROCYTE PYRUVATE KINASE ACTIVATOR ETAVOPIVAT IN PATIENTS WITH THALASSEMIA OR SICKLE CELL DISEASE
COATES T.,
LAL A.,
BROWN R.,
KALFA T.,
KWIATKOWSKI J.,
BREVARD J.,
TRENOR C.,
WOOD K.,
SHETH S.
Affiliations
COATES T.
1 University of Southern California Keck School of Medicine, Los Angeles, UNITED STATES
LAL A.
2 University of California San Francisco, San Francisco, UNITED STATES
BROWN R.
3 Children’s Healthcare of Atlanta, Atlanta, UNITED STATES
KALFA T.
4 Cincinnati Children’s Hospital Medical Center, Cincinnati, UNITED STATES
KWIATKOWSKI J.
5 Children’s Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, UNITED STATES
BREVARD J.
6 Forma Therapeutics, Inc., Watertown, UNITED STATES
TRENOR C.
6 Forma Therapeutics, Inc., Watertown, UNITED STATES
WOOD K.
6 Forma Therapeutics, Inc., Watertown, UNITED STATES
